189 related articles for article (PubMed ID: 26673754)
1. Serological epitope profile of anti-Ro52-positive patients with systemic autoimmune rheumatic diseases.
Infantino M; Meacci F; Grossi V; Benucci M; Morozzi G; Tonutti E; Tampoia M; Ott A; Meyer W; Atzeni F; Sarzi-Puttini P; Manfredi M; Bizzaro N
Arthritis Res Ther; 2015 Dec; 17():365. PubMed ID: 26673754
[TBL] [Abstract][Full Text] [Related]
2. Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic Sclerosis.
Gkoutzourelas A; Liaskos C; Mytilinaiou MG; Simopoulou T; Katsiari C; Tsirogianni A; Daoussis D; Scheper T; Meyer W; Bogdanos DP; Sakkas LI
Front Immunol; 2018; 9():2835. PubMed ID: 30581434
[TBL] [Abstract][Full Text] [Related]
3. Clinical associations of the positive anti Ro52 without Ro60 autoantibodies: undifferentiated connective tissue diseases.
Murng SHK; Thomas M
J Clin Pathol; 2018 Jan; 71(1):12-19. PubMed ID: 28663326
[TBL] [Abstract][Full Text] [Related]
4. Preferential recognition of the phosphorylated major linear B-cell epitope of La/SSB 349-368 aa by anti-La/SSB autoantibodies from patients with systemic autoimmune diseases.
Terzoglou AG; Routsias JG; Avrameas S; Moutsopoulos HM; Tzioufas AG
Clin Exp Immunol; 2006 Jun; 144(3):432-9. PubMed ID: 16734612
[TBL] [Abstract][Full Text] [Related]
5. Epitope mapping with synthetic peptides of 52-kD SSA/Ro protein reveals heterogeneous antibody profiles in human autoimmune sera.
Ricchiuti V; Briand JP; Meyer O; Isenberg DA; Pruijn G; Muller S
Clin Exp Immunol; 1994 Mar; 95(3):397-407. PubMed ID: 7511075
[TBL] [Abstract][Full Text] [Related]
6. The 52 000 MW Ro/SS-A autoantigen in Sjögren's syndrome/systemic lupus erythematosus (Ro52) is an interferon-gamma inducible tripartite motif protein associated with membrane proximal structures.
Rhodes DA; Ihrke G; Reinicke AT; Malcherek G; Towey M; Isenberg DA; Trowsdale J
Immunology; 2002 Jun; 106(2):246-56. PubMed ID: 12047754
[TBL] [Abstract][Full Text] [Related]
7. Anti-SLA/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis.
Zachou K; Gampeta S; Gatselis NK; Oikonomou K; Goulis J; Manoussakis MN; Renaudineau Y; Bogdanos DP; Dalekos GN
Liver Int; 2015 Feb; 35(2):660-72. PubMed ID: 25113420
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic utility of anti-Ro52 detection in systemic autoimmunity.
Dugar M; Cox S; Limaye V; Gordon TP; Roberts-Thomson PJ
Postgrad Med J; 2010 Feb; 86(1012):79-82. PubMed ID: 20145055
[TBL] [Abstract][Full Text] [Related]
9. Clinical associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies: Diagnostic utility of their separate detection.
Menéndez A; Gómez J; Escanlar E; Caminal-Montero L; Mozo L
Autoimmunity; 2013 Feb; 46(1):32-9. PubMed ID: 23039326
[TBL] [Abstract][Full Text] [Related]
10. Association of anti-Ro52, anti-Ro60 and anti-La antibodies with diagnostic, clinical and laboratory features in a referral hospital in Jerez, Spain.
Menor Almagro R; Jurado Roger A; Rodríguez Gutiérrez FJ; Solís Díaz R; Cardiel MH; Salaberri Maestrojuan JJ
Reumatol Clin; 2016; 12(5):256-62. PubMed ID: 26725021
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: results of a multicentric study.
Ghillani P; André C; Toly C; Rouquette AM; Bengoufa D; Nicaise P; Goulvestre C; Gleizes A; Dragon-Durey MA; Alyanakian MA; Chretien P; Chollet-Martin S; Musset L; Weill B; Johanet C
Autoimmun Rev; 2011 Jul; 10(9):509-13. PubMed ID: 21447407
[TBL] [Abstract][Full Text] [Related]
12. Fine specificity of autoantibodies to La/SSB: epitope mapping, and characterization.
Tzioufas AG; Yiannaki E; Sakarellos-Daitsiotis M; Routsias JG; Sakarellos C; Moutsopoulos HM
Clin Exp Immunol; 1997 May; 108(2):191-8. PubMed ID: 9158085
[TBL] [Abstract][Full Text] [Related]
13. Structurally derived mutations define congenital heart block-related epitopes within the 200-239 amino acid stretch of the Ro52 protein.
Ottosson L; Salomonsson S; Hennig J; Sonesson SE; Dörner T; Raats J; Kuchroo VK; Sunnerhagen M; Wahren-Herlenius M
Scand J Immunol; 2005 Feb; 61(2):109-18. PubMed ID: 15683447
[TBL] [Abstract][Full Text] [Related]
14. Latest update on the Ro/SS-A autoantibody system.
Schulte-Pelkum J; Fritzler M; Mahler M
Autoimmun Rev; 2009 Jun; 8(7):632-7. PubMed ID: 19393201
[TBL] [Abstract][Full Text] [Related]
15. Anti-SSA/Ro52 autoantibodies blocking the cardiac 5-HT4 serotoninergic receptor could explain neonatal lupus congenital heart block.
Eftekhari P; Sallé L; Lezoualc'h F; Mialet J; Gastineau M; Briand JP; Isenberg DA; Fournié GJ; Argibay J; Fischmeister R; Muller S; Hoebeke J
Eur J Immunol; 2000 Oct; 30(10):2782-90. PubMed ID: 11069058
[TBL] [Abstract][Full Text] [Related]
16. Ro52 autoantibodies arise from self-reactive progenitors in a mother of a child with neonatal lupus.
Reed JH; Gorny MK; Li L; Cardozo T; Buyon JP; Clancy RM
J Autoimmun; 2017 May; 79():99-104. PubMed ID: 28118945
[TBL] [Abstract][Full Text] [Related]
17. Fine specificity of the Ro/SSA autoantibody response in relation to serological and clinical findings in 96 patients with self-reported cutaneous symptoms induced by the sun.
Popovic K; Brauner S; Ek M; Wahren-Herlenius M; Nyberg F
Lupus; 2007; 16(1):10-7. PubMed ID: 17283579
[TBL] [Abstract][Full Text] [Related]
18. Clinical subsets associated with different anti-aminoacyl transfer RNA synthetase antibodies and their association with coexisting anti-Ro52.
Yamasaki Y; Satoh M; Mizushima M; Okazaki T; Nagafuchi H; Ooka S; Shibata T; Nakano H; Ogawa H; Azuma K; Maeda A; Tonooka K; Ito H; Takakuwa Y; Inoue M; Mitomi H; Kiyokawa T; Tsuchida K; Matsushita H; Mikage H; Murakami Y; Chan JY; Ozaki S; Yamada H
Mod Rheumatol; 2016; 26(3):403-9. PubMed ID: 26344678
[TBL] [Abstract][Full Text] [Related]
19. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
[TBL] [Abstract][Full Text] [Related]
20. Presence of anti-TIF-1γ, anti-Ro52, anti-SSA/Ro60 and anti-Su/Ago2 antibodies in breast cancer: a cross-sectional study.
Vázquez-Del Mercado M; Martínez-García EA; Daneri-Navarro A; Gómez-Bañuelos E; Martín-Márquez BT; Pizano-Martínez O; Wilson-Manríquez EA; Corona-Sánchez EG; Chavarria-Avila E; Sandoval-García F; Satoh M
Immunopharmacol Immunotoxicol; 2021 Jun; 43(3):328-333. PubMed ID: 33876712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
